KODK
Eastman Kodak CompanyEastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide. The company operates through Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment offers digital offset plate and computer-to-plate imaging solutions to commercial industries, including commercial print, direct mail, book publishing, newspapers
2-Year Price History
Quarterly Financials & Projections
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Est | 2028-Q1 | 275.0 | 17.9 | -- | -11.0 | -- | -8.3 | -5.5 | 350.8 | -- | -- | -- | -- | -- |
| Est | 2027-Q4 | 300.0 | 30.0 | -- | -3.0 | -- | 18.0 | -9.0 | 359.0 | -- | -- | -- | -- | -- |
| Est | 2027-Q3 | 285.0 | 29.9 | -- | -1.4 | -- | 14.3 | -7.1 | 341.0 | -- | -- | -- | -- | -- |
| Est | 2027-Q2 | 280.0 | 25.2 | -- | -7.0 | -- | 8.4 | -7.0 | 326.8 | -- | -- | -- | -- | -- |
| Est | 2027-Q1 | 270.0 | 14.9 | -- | -13.5 | -- | -13.5 | -5.4 | 318.4 | -- | -- | -- | -- | -- |
| Est | 2026-Q4 | 295.0 | 28.0 | -- | -5.9 | -- | 14.8 | -8.9 | 331.9 | -- | -- | -- | -- | -- |
| Est | 2026-Q3 | 280.0 | 28.0 | -- | -2.8 | -- | 12.6 | -7.0 | 317.1 | -- | -- | -- | -- | -- |
| Est | 2026-Q2 | 275.0 | 23.4 | -- | -9.6 | -- | 5.5 | -6.9 | 304.5 | -- | -- | -- | -- | -- |
| Act | 2026-Q1 | 265.0 | 8.0 | 1.0 | -16.0 | -30.0 | -36.0 | -6.0 | 299.0 | 198.0 | 89.8 | 1.3% | 1.3x | 10.6x |
| Act | 2025-Q4 | 290.0 | 20.0 | 12.0 | -108.0 | 489.0 | 483.0 | -6.0 | 337.0 | 250.0 | 89.8 | 12.5% | 1.3x | 6.8x |
| Act | 2025-Q3 | 269.0 | 41.0 | 19.0 | 13.0 | 21.0 | 17.0 | -4.0 | 168.0 | 549.0 | 89.8 | 9.5% | 2.3x | 9.2x |
| Act | 2025-Q2 | 263.0 | -2.0 | -5.0 | -26.0 | 8.0 | -4.0 | -12.0 | 155.0 | 534.0 | 80.9 | -3.7% | -0.1x | 8.6x |
| Act | 2025-Q1 | 247.0 | 16.0 | -13.0 | -7.0 | -38.0 | -50.0 | -12.0 | 158.0 | 509.0 | 80.6 | -9.4% | 1.1x | 5.9x |
| Act | 2024-Q4 | 266.0 | 45.0 | -8.0 | 26.0 | 4.0 | -13.0 | -17.0 | 201.0 | 499.0 | 80.5 | -5.2% | 3.0x | 3.5x |
| Act | 2024-Q3 | 261.0 | 43.0 | -8.0 | 18.0 | -21.0 | -41.0 | -20.0 | 214.0 | 494.0 | 92.4 | -3.3% | 3.1x | 4.1x |
| Act | 2024-Q2 | 267.0 | 48.0 | 2.0 | 26.0 | -7.0 | -16.0 | -9.0 | 251.0 | 489.0 | 92.4 | 0.6% | 3.2x | 3.4x |
| Act | 2024-Q1 | 249.0 | 57.0 | 7.0 | 32.0 | 17.0 | 7.0 | -10.0 | 262.0 | 485.0 | 91.3 | 2.5% | 3.8x | 2.6x |
| Act | 2023-Q4 | 275.0 | 24.0 | -13.0 | 5.0 | 17.0 | 0.0 | -17.0 | 255.0 | 495.0 | 79.6 | -5.6% | 1.5x | 2.8x |
| Act | 2023-Q3 | 269.0 | 53.0 | 2.0 | 2.0 | 0.0 | -4.0 | -4.0 | 246.0 | 491.0 | 79.5 | 0.8% | 3.8x | 3.1x |
| Act | 2023-Q2 | 295.0 | 66.0 | 10.0 | 35.0 | 7.0 | 1.0 | -6.0 | 223.0 | 367.0 | 93.0 | 3.8% | 6.0x | 2.8x |
| Act | 2023-Q1 | 278.0 | 60.0 | 5.0 | 33.0 | 14.0 | 9.0 | -5.0 | 225.0 | 365.0 | 92.2 | 1.4% | 5.5x | 2.7x |
| Act | 2022-Q4 | 305.0 | 24.0 | -1.0 | 7.0 | 14.0 | 2.0 | -12.0 | 217.0 | 363.0 | 80.4 | -0.4% | 2.2x | 5.1x |
| Act | 2022-Q3 | 289.0 | 24.0 | -7.0 | 2.0 | -27.0 | -37.0 | -10.0 | 216.0 | 361.0 | 79.0 | -3.5% | 2.4x | -- |
| Act | 2022-Q2 | 321.0 | 35.0 | 1.0 | 20.0 | -60.0 | -64.0 | -4.0 | 289.0 | 360.0 | 90.2 | 0.5% | 3.5x | -- |
| Act | 2022-Q1 | 290.0 | 18.0 | -19.0 | -3.0 | -43.0 | -48.0 | -5.0 | 309.0 | 311.0 | 78.7 | -12.1% | 2.0x | -- |
Multiples vs the company's own history — cheap or rich relative to itself? Historical fiscal years, then TTM, then forward projections (E). Forward rows hold today's price against projected earnings, so the multiple compresses if the company grows into it.
| Year | Price | Rev Gr | EBITDA % | EBITDA | EV/EBITDA | EV/FCF | P/E | P/S |
|---|---|---|---|---|---|---|---|---|
| 2022 | 3.05 | — | 8.4% | 101 | 5.1× | n/m | 14.2× | 0.3× |
| 2023 | 3.90 | -7.3% | 18.2% | 203 | 2.8× | 93.6× | 4.3× | 0.3× |
| 2024 | 6.57 | -6.6% | 18.5% | 193 | 3.5× | n/m | 3.6× | 0.3× |
| 2025 | 8.46 | +2.5% | 7.0% | 75 | 6.8× | 1.1× | n/m | 0.6× |
| TTM | 9.92 | +4.4% | 6.2% | 67 | 0.0× | 0.0× | 0.0× | 0.0× |
| 2027E | 9.92 | +4.4% | 0.1% | 1 | 0.0× | 0.0× | 0.0× | 0.0× |
EBITDA in reporting-currency $M. Historical multiples use year-end market cap (split-adjusted price history); TTM & forward years use today's.
AI Analysis
LLM Evaluations
Kodak is a legacy industrial company in managed decline masquerading as a transformation story. While the pension reversion was a masterful one-time balance sheet fix, the core business generates anemic cash flow with EBITDA margins of 4-10% on ~$1.1B annual revenue, secular headwinds in its largest segment (print plates declining 2-3%/year), and early-stage pivots to pharma/battery chemicals that are years from meaningful contribution. The stock trades at an inflated P/S of 1.0x and a misleading P/FCF of 2.4x driven by a one-time $484M pension-related cash inflow in Q4 2025. Normalized FCF is likely $15-40M annually, implying a fair EV/FCF of 22-58x — far from cheap. Ongoing dilution from Series B preferred conversion at $10/share (11%+ annual dilution), toxic derivative volatility on the P&L, volatile commodity exposure, and aggressive debt prepayment requirements create a hostile setup for common equity holders. The 22% post-earnings crash in Q1 2026 reflects the market waking up to the gap between narrative and fundamentals.
Latest Earnings Call
Transcript Summary
Eastman Kodak reported a strong Q1 2026, with revenue rising 7% year-over-year to $265 million and operational EBITDA climbing to $15 million from $2 million. This performance marks the third consecutive quarter of growth, reflecting the success of a long-term strategic transformation. The company’s Print segment grew by 9%, while the Advanced Materials and Chemicals (AM&C) division benefited from a resurgence in film demand for motion pictures and still photography. Kodak is also diversifying into the pharmaceutical market through its new cGMP facility and a research partnership with SUNY Geneseo. A key financial milestone was the company’s transition to a net debt positive position of $139 million, supported by $299 million in unrestricted cash. Although the company reported a GAAP net loss of $16 million, CFO David Bullwinkle clarified that this was primarily due to non-cash accounting adjustments related to preferred stock derivatives and pension plan terminations. Management remains focused on operational excellence and navigating commodity price volatility, particularly for silver and aluminum, while continuing to invest in growth products. The leadership team emphasized their commitment to manufacturing and service as the foundation for long-term shareholder value.
Valuation & Metrics
Market Stats
TTM Financial Snapshot
DCF Fair Value Estimate
Forward Outlook & Risk
Short Interest
Options
| Strike | Call Bid/Ask | Call OI | Put Bid/Ask | Put OI |
|---|---|---|---|---|
| $5.00 | $4.60/$5.20 | 1,539 | --/$0.75 | 177 |
| $6.00 | $3.60/$4.30 | 0 | --/$0.75 | 0 |
| $7.50 | $2.25/$2.85 | 2,118 | $0.05/$0.35 | 183 |
| $9.00 | $1.00/$1.75 | 2 | $0.35/$0.95 | 40 |
| $10.00 | $0.75/$1.10 | 1,354 | $1.00/$1.10 | 179 |
| $11.00 | $0.05/$0.90 | 0 | $1.40/$2.30 | 0 |
| $12.50 | $0.30/$0.50 | 1,051 | $2.50/$3.70 | 62 |
| $14.00 | --/$0.75 | 0 | $3.90/$5.10 | 0 |
Forward Projections & Estimates
Employees
Institutional Ownership
Headline & net flow
In Q1 2026 so far (quarter still filing), institutions are net buyers — bought 8.8% of float, sold 4.6%. 1 filer moved >1% of shares (0 buying, 1 selling).
Ownership composition
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| BlackRock, Inc.Passive | $41.1M | $5.31 | +$6.5M | −$2.4M | -0.2% | $5.69T |
| VANGUARD CAPITAL MANAGEMENT LLCPassive | $33.3M | $9.05 | +$33.3M | +$33.3M | — | $4.04T |
| MARSHALL WACE, LLP | $24.9M | $6.06 | −$9.7M | +$8.6M | +0.6% | $92.71B |
| DIMENSIONAL FUND ADVISORS LPPassive | $19.7M | $5.08 | +$1.0M | −$3.3M | -0.4% | $480.92B |
| STATE STREET CORPPassive | $18.3M | $5.62 | +$1.2M | −$324K | -0.2% | $2.89T |
| VANGUARD PORTFOLIO MANAGEMENT LLCPassive | $15.2M | $9.05 | +$15.2M | +$15.2M | — | $1.91T |
| GEODE CAPITAL MANAGEMENT, LLCPassive | $14.7M | $6.03 | +$2.1M | +$418K | +2.3% | $1.61T |
| GOLDMAN SACHS GROUP INC | $9.6M | $6.62 | +$2.1M | +$8.1M | -0.2% | $760.93B |
| MILLENNIUM MANAGEMENT LLC | $9.6M | $5.97 | +$4.7M | +$7.9M | -0.5% | $127.40B |
| TWO SIGMA INVESTMENTS, LP | $8.2M | $7.06 | +$2.7M | +$7.6M | -0.9% | $117.03B |
| JANE STREET GROUP, LLCMM | $7.5M | $7.05 | −$6.1M | +$5.5M | -0.1% | $92.10B |
| D. E. Shaw & Co., Inc. | $6.8M | $6.67 | −$306K | +$6.6M | -0.3% | $118.02B |
| WELLS FARGO & COMPANY/MN | $6.7M | $5.67 | +$594K | −$4.0M | -0.2% | $497.71B |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $6.2M | $5.03 | +$317K | −$420K | -2.3% | $4.93B |
| AQR CAPITAL MANAGEMENT LLC | $5.4M | $6.22 | +$4.9M | +$3.9M | -0.2% | $218.19B |
| NORTHERN TRUST CORPPassive | $4.6M | $6.31 | +$914K | −$1.3M | -0.2% | $755.34B |
| VANGUARD FIDUCIARY TRUST COPassive | $4.3M | $9.05 | +$4.3M | +$4.3M | — | $395.83B |
| Empowered Funds, LLC | $3.5M | $5.42 | +$317K | −$420K | +0.2% | $15.64B |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | $3.4M | $5.86 | +$0 | +$3.4M | -0.2% | $993M |
| Point72 Asset Management, L.P. | $3.2M | $8.65 | +$1.5M | +$3.2M | +0.9% | $54.88B |
Trading behavior
▸ Compare to holder-profile behavior (across all their stocks)
Biggest decreases this quarter
New buyers this quarter
Top-5 holders · 45.5%
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
Analyst Coverage
| Quarter | Revenue | EBITDA | Net Inc | EPS | EPS Range | # Analysts |
|---|---|---|---|---|---|---|
| 2022 Q1 | 2.0B | -785M | -768M | $1.43 | $1.43 – $1.43 | 6 |
| 2022 Q2 | 3.0B | -122M | -320M | $1.15 | $1.15 – $1.15 | 6 |
| 2022 Q3 | 4.0B | -165M | -470M | $1.27 | $1.27 – $1.27 | 6 |
| 2022 Q4 | 1.5B | -266M | -871M | $1.95 | $1.95 – $1.95 | 6 |
| 2023 Q1 | 2.2B | -863M | -845M | $1.43 | $1.43 – $1.43 | 9 |
| 2023 Q2 | 3.3B | -134M | -352M | $1.19 | $1.19 – $1.19 | 9 |
| 2023 Q3 | 4.4B | -181M | -517M | $1.39 | $1.39 – $1.39 | 9 |
| 2023 Q4 | 1.7B | -293M | -958M | $2.09 | $2.09 – $2.09 | 1 |
| 2024 Q1 | 2.5B | -949M | -929M | $1.58 | $1.58 – $1.58 | 1 |
| 2025 Q3 | 269M | 89M | 0M | $0.00 | $0.00 – $0.00 | 0 |
Corporate
Executive Compensation (2023-2025)
Insider Trading (last 12mo)
| Date | Side | Insider | Title | Shares | Price | Dollars | Owned $ |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | BUY | Katz Philippe D | director, 10 percent owner: | 2,000 | $10.30 | $21K | $1.93M |
| 2025-12-05 | BUY | KENNEDY LEWIS MANAGEMENT LP | director | 1,000,000 | $0.00 | $0 | $0 |
| 2025-12-05 | BUY | Kennedy Lewis Investment Holdings II LLC | director | 1,000,000 | $0.00 | $0 | $0 |
| 2025-11-17 | BUY | Katz Philippe D | director, 10 percent owner: | 5,000 | $7.35 | $37K | $1.36M |
| 2025-11-10 | SELL | Byrd Roger W. | officer: General Counsel, Sec., SVP | 19,744 | $8.00 | $158K | $474K |
| 2025-08-14 | BUY | CONTINENZA JAMES V | director, officer: Executive Chairman and CEO | 50,000 | $5.74 | $287K | $10.92M |
| 2025-08-14 | BUY | Katz Philippe D | director, 10 percent owner: | 10,000 | $5.67 | $57K | $1.02M |
Order Flow (FINRA, ~3w lag)
Revenue Breakdown
Revenue Segments
| Other | $9.0M | +13% |
| Growth Products | $1.0M | +0% |
| North America | $138.0M | +13% |
| EMEA | $75.0M | +0% |
| Asia Pacific | $49.0M | +7% |
| Latin America | $3.0M | -25% |
Filing Risk Analysis
Filing Risk Scores
EASTMAN KODAK COMPANY: A Forensic Autopsy of Structural Deficit and Preferred Stock Predation
Counter-Thesis
Counter-Thesis & Recent News
Kodak's Q1 2026 earnings report (May 2026) triggered a massive 22% share price crash after the company revealed a GAAP net loss of $16 million, more than double the $7 million loss from the previous year, despite a 7% rise in revenue to $265 million. Additionally, in March 2026, multiple lawsuits were filed against the company following a fatal incident at the Kodak Center, alleging gross security failures and negligence (Source: MarketBeat, Democrat and Chronicle).
The core bear thesis revolves around 'managed decline.' While management touts revenue growth in specialty segments, critics point out that annual revenue has steadily slid from $1.2 billion in 2022 to roughly $1.0 billion by 2025. The company’s pivot to industrial chemicals and pharmaceuticals is capital-intensive and faces margin pressure from rising commodity prices (silver/aluminum). The recent widening net loss and negative return on equity (-19.99%) suggest that operational improvements are being offset by debt servicing and restructuring costs (Source: Forbes, MarketBeat).
KODK is currently flagged as 'overvalued' relative to its fair value by technical analysts, with a negative P/E ratio and a widening GAAP net loss. A significant red flag is the 11.97% negative net margin reported in Q1 2026. Furthermore, analyst Weiss Ratings recently cut the stock to a 'Sell' (April 2024), and MarketBeat maintains an overall 'Sell' consensus. The company also faces lower non-cash pension income following the termination of its retirement plan, which will continue to weigh on quarterly results through 2026 (Source: Investing.com, MarketBeat).
In its primary Print segment, Kodak faces intense pressure from well-capitalized digital incumbents like HP, Canon, and Fujifilm. Traditional offset printing plate demand—a legacy stronghold for Kodak—is declining at a rate of 2-3% annually as the industry shifts to digital. In the Advanced Materials & Chemicals division, Kodak is entering highly fragmented and competitive markets for battery chemicals and pharmaceuticals, where it lacks the scale of established specialty chemical rivals (Source: Matrix BCG, PitchGrade).
Customer sentiment is polarized; while the brand retains 'legacy' love in the film and cinema community, commercial and B2B sentiment is pressured by a perceived lack of innovation compared to rivals like Sony or Apple. Market analysts note that Kodak's marketing is insufficient to capture new digital-native customers, leaving it reliant on a shrinking base of analog users and industrial partners (Source: PESTLE Analysis, Quartr).
Full Earnings Call Transcript
Full Earnings Call Transcript — Q1 • 2026-05-08
Operator: Good day, and thank you for standing by. Welcome to the Eastman Kodak Q1 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would like to hand over the conference to our first speaker today, Denisse Goldbarg. Denisse Goldbarg: Thank you, and good afternoon, everyone. I am Denisse Goldbarg, Eastman Kodak's Chief Marketing Officer. Welcome to Kodak's First Quarter 2026 Earnings Call. At 4:15 this afternoon, Kodak filed its Form 10-Q and issued its release on financial results for the first quarter of 2026. You may access the presentation and webcast for today's call on our Investor Center at investor.kodak.com. During today's conference call, we will be making certain forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. We intend for these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Investors are cautioned not to unduly rely on forward-looking statements, and such statements should not be read or understood as a guarantee of future performance or results. All forward-looking statements are based on Kodak's expectations and various assumptions. Future events or results may differ from those anticipated or expressed in the forward-looking statements. Important factors that could cause actual events or results to differ materially from these forward-looking statements include, among others, the risks, uncertainties and other factors described in more detail in Kodak's filings with the U.S. Securities and Exchange Commission from time to time. All forward-looking statements attributable to Kodak or persons acting on its behalf only apply as of the date of this presentation and are expressly qualified in their entirety by the cautionary statements included or referenced in this presentation. Kodak undertakes no obligation to update or revise forward-looking statements or reflect events or circumstances that may arise after the date made or to reflect the occurrence of unanticipated events. In addition, the release just issued and the presentation provided contains certain measures that are deemed non-GAAP measures. Reconciliations to the most directly comparable GAAP measures have been provided with the release on our website in our Investor Center at investor.kodak.com. Speakers on today's call are Jim Continenza, Kodak's Executive Chairman and Chief Executive Officer; and David Bullwinkle, Kodak's Chief Financial Officer and Senior Vice President. We will not be holding a formal Q&A during today's call. As always, the Investor Relations team is available for follow-up. I will now turn the call over to Jim. Thank you, and have a great day. James Continenza: Welcome, everyone, and thank you for joining the First Quarter 2026 Investor Call for Eastman Kodak. The story of the first quarter is a story of consistency, stability and growth. This reflects our transformation over the last 7 years and our focus on execution and our continued investment in the business. Now I'm pleased to see strong year-over-year performance over the last 3 consecutive quarters. Let me give you some highlights from the first quarter. Consolidated revenue is up 7% to $265 million compared with $247 million for first quarter 2025. Revenue increased in both our key businesses, print and AM&C. We had gross profit percentage of 22%. That's 3 percentage points or 16% higher than first quarter 2025. Operational EBITDA was $15 million compared with $2 million for the first quarter 2025, up $13 million. Moving on to Advanced Materials and Chemicals. We saw AM&C revenue grew by $2 million or 3%, which was driven by a $3 million increase in film and chemicals, which was partially offset by $1 million for lower inks and consumables. Let's talk about our still films. We've invested heavily back into film, and we're starting to see great results from that. An example, in still film, recently launched a professional film sold directly to distributors. Our objective is to stabilize the market and continue to meet demand. I am really proud to see motion picture continue to increase. We launched a new film called VERITA 200D, which was used in Euphoria Season 3. A lot is going on. Many Oscar winning movies, including One Battle After Another and Sinners were shot on Kodak film and the long-anticipated Christopher Nolan's The Odyssey is also shot on Kodak film. We remain committed to film and maintaining supply for our customers. A quick update on our Pharma business. Our new cGMP pharmaceutical manufacturing facility is up and running. I am really proud to say we recently opened the Kodak Advanced Electrophysiology Lab in partnership with SUNY Geneseo. The lab will enhance our research capabilities and support future product development. We continue to work towards obtaining Class 2 certification to manufacture more complex, high-margin products in the United States. Moving on to some highlights from our commercial print business. We continue to provide a full range of print solutions to our customers. Our revenues increased by 9%, even in the difficult times we're going through. There are some supply issues on aluminum. There is issues on delivery, logistics. A lot is going on. Prices have increased greatly on raw materials such as aluminum, but yet we're still able to maintain our revenue and supply our customers. As our commitment to print continues, and we continue to invest in innovation, I'm pleased to announce we recently launched the SONORA UltraXR plate in Europe, which will expand our SONORA Ultra portfolio. As I stated last quarter, and I'll state it again, as we continue to fix the balance sheet, invest in the infrastructure of the business, and focus on key products, our next steps are growth. We must continue to grow our business. We have built a stable, growing Kodak by consistently executing our long-term plan. We stay on track regardless of all the events happening around us. We're leveraging our core strengths. We're strengthening our balance sheet. We're investing in growth products. As we continue to invest in operational excellence and execution, right, we continue to diversify our portfolio by using the different technologies and skill sets we have in the business. As we stated before, right, our goal is to continue to work on the balance sheet. I'm proud to say today, we are net debt positive. One of the most important aspects is by meeting our customers' needs. And the only way we can do that is by continuing to focus on operational excellence. We have to be better than everyone else, and we're going to continue to keep investing and getting better every single year. Now I'm going to turn it over to Dave Bullwinkle to discuss our first quarter financial results. Dave? David Bullwinkle: Thanks, Jim, and welcome to the call, everybody. Thanks for joining us today. This afternoon, the company filed its Form 10-Q for the quarter ended March 31, 2026, with the SEC. As I do on each and every call, I encourage you to read the filing in its entirety as there is a plethora of information contained in the materials we have provided publicly. As a reminder, references made during my remarks are included in the company's earnings press release and Form 10-Q filed today. So let's begin with the key financial highlights for the first quarter of 2026. We delivered strong financial performance despite sharp commodity swings and persistent inflationary pressure. The results reflect substantial year-over-year improvement in revenue, gross profit and operational EBITDA, underscoring our disciplined execution and progress against our long-term goals. In fact, this is the third consecutive quarter of year-over-year growth for these measures. Key metrics. Revenue was $265 million, an increase of $18 million or 7% year-over-year with increases in Print, Advanced Materials and Chemicals. On a constant currency basis, revenue grew $11 million or 4%. Gross profit was $57 million, which is up $11 million or 24% year-over-year. Our gross profit percentage increased to 22% compared to 19% in the prior year quarter, reflecting our operational execution. Operational EBITDA for the quarter was $15 million, and that's an increase of $13 million compared to the prior year quarter, primarily driven by improved pricing, partially offset by higher manufacturing costs and higher silver and aluminum prices. For the quarter, we reported a GAAP net loss of $16 million compared with a GAAP net loss of $7 million in the prior year quarter, an increase of $9 million. Let me walk you through the main factors behind this result and share with you some additional helpful information. $12 million of the loss was driven by a change in the fair value of an embedded derivative related to our Series B preferred stock. This accounting impact resulted from our previously announced amendment to the Series B agreement and the change in fair value was primarily caused by the increase in our stock price during the quarter. This is fully disclosed in our Form 10-Q. $5 million of the loss relates to stock-based compensation expense, which is a noncash expense and does not impact our liquidity. We also recognized $4 million of noncash pension income this quarter, but this reflects an $18 million decrease compared to the prior year quarter. This is driven by the termination of the KRIP pension plan, which we completed in the fourth quarter of 2025. As a result of the planned termination, we expect pension income to be lower year-over-year in each quarter of 2026. So we will see this reoccur every quarter this year. Partially offsetting these items, GAAP net loss benefited from an $8 million year-over-year reduction in interest expense, mainly due to term loan repayments resulting from the pension plan termination and reversion. While these items affect comparability, they reflect deliberate actions we took to strengthen our balance sheet, reduce debt and build long-term value. Now that I've explained some of the key drivers of the year-over-year change in our net loss, I've also included a simple reconciliation in today's materials to explain how the GAAP net loss translates to operational EBITDA. We received feedback from investors and questions about this, so we're covering it here. EBITDA measures the profitability of our business by excluding its components of interest, taxes and noncash charges like depreciation and amortization. As you know, EBITDA stands for earnings before interest, taxes, depreciation and amortization. To arrive at operational EBITDA from net loss, we start by adding back those standard items of interest expense, tax expense and depreciation and amortization expense. In addition, to arrive at operational EBITDA for Kodak, we remove those nonoperational items shown on the waterfall slide. Number one, nonrecurring and other items. This category primarily contains the $12 million expense we booked in the quarter for the fair value change in the preferred stock derivative. This derivative is the value of the conversion option for our stock. We expect to fair value this every quarter, and the changes will be recognized in our income statement. Second category are noncash items of expense or income. In this case, it is a net expense item. This represents an adjustment to remove stock-based compensation expense, which we talked about earlier, and it's almost fully offset by the corporate component of pension income, which we also discussed earlier in my remarks. As I have said, these adjustments remove the impact of items that can cause GAAP volatility, but do not reflect day-to-day operations. Therefore, we consider them nonoperational. The resulting operational EBITDA provides a clear view of how our underlying business is performing. We've consistently used this metric as our segment measure as well, which is disclosed in all of our earnings releases and fully reconciled in that material. I hope this provides helpful context of the company's performance and financial statements. If you have further questions, please don't hesitate to contact us. Moving on to our cash performance for the first quarter. We ended the quarter with $299 million of unrestricted cash, a decrease of $38 million from December 31, 2025. Let me briefly walk through the key drivers of our quarter end cash position. First, as expected, we received $46 million in cash proceeds from the redemption of hedge fund investments related to the KRIP pension reversion during the quarter. Second, working capital was impacted by a $38 million increase in inventory with $35 million of this increase occurring within our AM&C segment. This was largely driven by average commodity cost of silver more than doubling from year-end and increases in the volume of silver we carry on the balance sheet due to supply terms. Inventory in AM&C also increased as we built ahead of a planned second quarter plant shutdown for maintenance. Partially offsetting these impacts within working capital, accounts payable increased by $9 million and accounts receivable decreased by $9 million, both helping to partially counter the inventory increases. Last, as required under the term loan amendment, we made a $50 million principal payment on our higher rate term loans in March. This was funded primarily by KRIP investment asset redemptions. These actions strengthen our liquidity profile and reduce future interest expense. As of March 31, 2026, the company's net debt positive position increased from $128 million at December 31, 2025, to $139 million at March 31, 2026. This is an $11 million improvement in the quarter. This reflects a further strengthening of our financial position. As I conclude, I want to leave you with a few clear takeaways from our first quarter results. Number one, financial results were strong. We delivered solid year-over-year growth in revenue, gross profit and operational EBITDA, and this is for the third consecutive quarter. We did this despite economic headwinds in commodity pricing and inflationary impacts as well. Most notably, our operational EBITDA increased sharply even as the business managed through those impacts. Again, as I talked about earlier, and we fully reconciled for you, operational EBITDA is our key internal measure of profitability. It's how we measure and disclose the results of our segments in our public filings as well. Finally, I am proud to say that our balance sheet is stronger than it's been in many, many years as we continue to see the benefit of the decisions we've made to reinforce our foundation. With $299 million of unrestricted cash, we are in a net debt positive position relative to our short- and long-term debt, and this is for the second consecutive quarter. We have also continued to delever the balance sheet, paying down $50 million of higher rate interest debt in the quarter. Thank you for your time and attention. I'll now return it back to Jim. James Continenza: Thank you, Dave. In summary, we've built a strong, stable Kodak over the last several years, by consistent execution of our long-term plan and making the appropriate changes in the environment as it changes around us. We have delivered 3 consecutive strong quarters year-over-year. We continue to invest in AM&C and print and grow those products. We focus on operations, but more importantly, 3 key areas that we always focus on manufacturing, selling and service. Everyone in the company is geared around focusing on those 3 areas. The goal is to deliver long-term value to our shareholders, our customers and our employees. With that, I want to thank everyone for their time and listening to the Eastman Kodak First Quarter 2026 Investor Call. Operator: Thank you for your participation in today's conference. This does conclude the program. You may now disconnect.